Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
MERCK SHARP & DOHME LLC (MRK) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/11/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
12/21/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
12/12/2022 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
11/21/2022 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
11/22/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/17/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/08/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/29/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/12/2021 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
10/01/2021 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
09/30/2021 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
04/01/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/22/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/04/2021 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
03/04/2021 3 Merck & Co., Inc. (10% Owner) has filed a Form 3 on Pandion Therapeutics, Inc.
02/25/2021 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
05/02/2012 ARS Form ARS - Annual Report to Security Holders
02/25/2011 NO ACT Form NO ACT - No Action Letter
02/03/2011 TRN Merck & Co.'s CEO Discusses Q4 2010 Results
01/20/2011 4/A Form 4/A - Statement of changes in beneficial ownership of securities [Amend]
11/22/2010 4/A REPRESAS CARLOS E (Director) has filed a Form 4 on MERCK SHARP & DOHME CORP.
Txns: Disposed of 1,000 shares @ $0
10/29/2010 TRN Merck CEO Discusses Q3 2010 Results
07/30/2010 TRN Merck & Co. Q2 2010 Earnings Call Transcript
05/04/2010 TRN Merck & Co. Q1 2010 Earnings Call Transcript
04/09/2010 NO ACT Form NO ACT - No Action Letter
04/09/2010 NO ACT Form NO ACT - No Action Letter
03/30/2010 10-K Annual Report for the period ended December 31, 2009
02/16/2010 TRN Merck & Co., Inc. Q4 2009 Earnings Call Transcript
01/12/2010 15-15D Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]
11/18/2009 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
11/10/2009 EFFECT Form EFFECT -
11/06/2009 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement
11/06/2009 POS AM Form POS AM - Post-Effective amendments for registration statement
11/06/2009 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy